What is PT-141 / Bremelanotide?
PT-141, also known as bremelanotide, is a melanocortin receptor agonist studied in neuroendocrine, behavioral, and sexual-function pathways.
What researchers study
- Melanocortin receptor signaling
- Neuroendocrine pathways
- Behavioral and sexual-function research
- Central nervous system melanocortin biology
Administration, dosing & shelf-life context
A regulated prescription bremelanotide product exists in the U.S. for a specific indication, but that product and regimen must not be extrapolated to this research vial. No self-administration instructions are provided.
No approved male dosing regimen should be inferred for this research-use vial.
A prescription bremelanotide product has a specific labeled regimen for eligible patients, but that regimen is not instructions for this research vial. No dose is provided here.
The current seller page does not publish a validated shelf-life duration for this vial. Use lot-specific expiry/BUD and COA information.
Follow the seller label and lot documentation. Do not assume that storage requirements for a prescription bremelanotide presentation apply to this research vial.
Research comparison ideas
These are literature/comparator ideas, not a recommendation to combine or co-administer compounds.
- Melanotan II as a melanocortin receptor research comparator
Evidence boundary
Bremelanotide has human clinical data in a specific regulated prescription context. The linked 10 mg research vial is a different commercial presentation and should remain clearly separated from that approved product context.
Research-use boundary: This educational profile does not diagnose, treat, prescribe, calculate doses, or provide a self-experimentation protocol.